Jilin Wu

机构：Peking University, Peking University People's Hospital · ORCID：0000-0003-1489-1441

发表论文 45 篇 · 总被引 530 次 · h-index 11

代表论文

• The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment (2023 · Cell & Bioscience · 被引 29)
• Tertiary Lymphoid Structures are Linked to Enhanced Antitumor Immunity and Better Prognosis in Muscle‐Invasive Bladder Cancer (2024 · Advanced Science · 被引 26)
• MT1G , an emerging ferroptosis‐related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer (2023 · Environmental Toxicology · 被引 20)
• Landscapes of gut bacterial and fecal metabolic signatures and their relationship in severe preeclampsia (2024 · Journal of Translational Medicine · 被引 18)
• SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation (2024 · International Journal of Biological Sciences · 被引 15)
• Graph theory-based analysis of functional connectivity changes in brain networks underlying cognitive fatigue: An EEG study (2025 · PLoS ONE · 被引 11)